letter_date string | posted_date string | company string | company_key string | issuing_office string | subject string | violation_categories string | response_letter bool | closeout_letter bool | letters_to_company int64 | first_letter string | latest_letter string | repeat_recipient bool | fed_uei string | fed_recipient_name string | fed_obligated_fy25_plus float64 | fed_top_agency string | in_ontology bool | letter_url string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-10-30 | 2026-11-03 | RonanRx, Inc. dba RonanRx | RONANRX INC DBA RONANRX | Center for Drug Evaluation and Research (CDER) | False & Misleading Claims/Misbranded (Telehealth) | Unapproved or misbranded drugs | false | false | 1 | 2026-10-30 | 2026-10-30 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ronanrx-inc-dba-ronanrx-737905-10302026 |
2026-10-29 | 2026-11-03 | Conroe Welding Supply, Inc. | CONROE WELDING SUPPLY | Center for Drug Evaluation and Research (CDER) | CGMP/Medical Gases/Adulterated | CGMP other or devices; Adulterated | false | false | 1 | 2026-10-29 | 2026-10-29 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/conroe-welding-supply-inc-731507-10292026 |
2026-10-27 | 2026-11-03 | Pritam International Private Limited | PRITAM INTERNATIONAL PRIVATE | Center for Drug Evaluation and Research (CDER) | CGMP/Finished Pharmaceuticals/Adulterated | CGMP drugs; CGMP other or devices; Adulterated | false | false | 1 | 2026-10-27 | 2026-10-27 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pritam-international-private-limited-738079-10272026 |
2026-10-27 | 2026-11-03 | whitedragonecigs.com | WHITEDRAGONECIGS COM | Center for Tobacco Products | Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded | Unapproved or misbranded drugs; Adulterated; Tobacco | false | false | 1 | 2026-10-27 | 2026-10-27 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/whitedragonecigscom-740497-10272026 |
2026-10-27 | 2026-11-03 | Guangzhou Jiugong Research And Development Biotechnology Co., Ltd. | GUANGZHOU JIUGONG RESEARCH AND DEVELOPMENT BIOTECHNOLOGY | Center for Drug Evaluation and Research (CDER) | CGMP/Finished Pharmaceuticals/Adulterated | CGMP drugs; CGMP other or devices; Adulterated | false | false | 1 | 2026-10-27 | 2026-10-27 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangzhou-jiugong-research-and-development-biotechnology-co-ltd-737769-10272026 |
2026-10-27 | 2026-11-03 | Guangdong Bisutang Biotechnology Co., Ltd. | GUANGDONG BISUTANG BIOTECHNOLOGY | Center for Drug Evaluation and Research (CDER) | Refusal to Provide Access to and Copying of Records | null | false | false | 1 | 2026-10-27 | 2026-10-27 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangdong-bisutang-biotechnology-co-ltd-733939-10272026 |
2026-10-26 | 2026-11-03 | Bella’s Nutri Shop Inc. | BELLA S NUTRI SHOP | Center for Drug Evaluation and Research (CDER) | Unapproved New Drugs/Misbranded | Unapproved or misbranded drugs | false | false | 1 | 2026-10-26 | 2026-10-26 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bellas-nutri-shop-inc-737491-10262026 |
2026-10-26 | 2026-11-03 | Phuoc Loc Tho Herbals, Inc. | PHUOC LOC THO HERBALS | Center for Drug Evaluation and Research (CDER) | Unapproved New Drugs/Misbranded | Unapproved or misbranded drugs | false | false | 1 | 2026-10-26 | 2026-10-26 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/phuoc-loc-tho-herbals-inc-736860-10262026 |
2026-10-26 | 2026-11-03 | Ong Tien USA LLC | ONG TIEN USA | Center for Drug Evaluation and Research (CDER) | Unapproved New Drugs/Misbranded | Unapproved or misbranded drugs | false | false | 1 | 2026-10-26 | 2026-10-26 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ong-tien-usa-llc-737352-10262026 |
2026-10-26 | 2026-11-03 | New Green Nutrition Inc. | NEW GREEN NUTRITION | Center for Drug Evaluation and Research (CDER) | Unapproved New Drugs/Misbranded | Unapproved or misbranded drugs | false | false | 2 | 2021-10-14 | 2026-10-26 | true | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/new-green-nutrition-inc-737576-10262026 |
2026-10-26 | 2026-11-03 | Guangdong Bangze Medicine Co., Ltd. | GUANGDONG BANGZE MEDICINE | Center for Drug Evaluation and Research (CDER) | CGMP/Finished Pharmaceuticals/Adulterated | CGMP drugs; CGMP other or devices; Adulterated | false | false | 1 | 2026-10-26 | 2026-10-26 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/guangdong-bangze-medicine-co-ltd-734509-10262026 |
2026-10-26 | 2026-11-03 | Natuzem | NATUZEM | Center for Drug Evaluation and Research (CDER) | Unapproved New Drugs/Misbranded | Unapproved or misbranded drugs | false | false | 1 | 2026-10-26 | 2026-10-26 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/natuzem-737558-10262026 |
2026-10-26 | 2026-11-03 | Jing Cheong Asia Inc. dba New York Tong Ren Tang | JING CHEONG ASIA INC DBA NEW YORK TONG REN TANG | Center for Drug Evaluation and Research (CDER) | Unapproved New Drugs/Misbranded | Unapproved or misbranded drugs | false | false | 1 | 2026-10-26 | 2026-10-26 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/jing-cheong-asia-inc-dba-new-york-tong-ren-tang-738200-10262026 |
2026-10-23 | 2026-10-27 | Best Chinese Medicines LLC | BEST CHINESE MEDICINES | Center for Drug Evaluation and Research (CDER) | Unapproved New Drugs | Unapproved or misbranded drugs | false | false | 1 | 2026-10-23 | 2026-10-23 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/best-chinese-medicines-llc-738556-10232026 |
2026-10-22 | 2026-10-27 | Sanrace Biotechnology Co., Ltd. | SANRACE BIOTECHNOLOGY | Center for Drug Evaluation and Research (CDER) | CGMP/Finished Pharmaceuticals/Adulterated | CGMP drugs; CGMP other or devices; Adulterated | false | false | 1 | 2026-10-22 | 2026-10-22 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sanrace-biotechnology-co-ltd-737549-10222026 |
2026-10-22 | 2026-10-27 | TSP Solutions Pte. Ltd. | TSP SOLUTIONS PTE | Center for Drug Evaluation and Research (CDER) | Request for Records/CGMP/Finished Pharmaceuticals/Adulterated | CGMP drugs; CGMP other or devices; Adulterated | false | false | 1 | 2026-10-22 | 2026-10-22 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tsp-solutions-pte-ltd-735071-10222026 |
2026-10-22 | 2026-10-27 | Northland Nuclear Medicine, LLC | NORTHLAND NUCLEAR MEDICINE | Center for Drug Evaluation and Research (CDER) | CGMP/Finished Pharmaceuticals/Adulterated | CGMP drugs; CGMP other or devices; Adulterated | false | false | 1 | 2026-10-22 | 2026-10-22 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/northland-nuclear-medicine-llc-736893-10222026 |
2026-10-16 | 2026-11-03 | US Tov Inc. dba US Trading Company | US TOV INC DBA US TRADING | Office of Inspections and Investigations | Foreign Supplier Verification Program (FSVP) | Food safety (FSVP, HACCP, CGMP food) | false | false | 1 | 2026-10-16 | 2026-10-16 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/us-tov-inc-dba-us-trading-company-739791-10162026 |
2026-10-14 | 2026-10-20 | Rohto Pharmaceutical Co., Ltd. | ROHTO PHARMACEUTICAL | Center for Drug Evaluation and Research (CDER) | CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated | CGMP drugs; CGMP other or devices; Unapproved or misbranded drugs; Adulterated | false | false | 1 | 2026-10-14 | 2026-10-14 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/rohto-pharmaceutical-co-ltd-733215-10142026 |
2026-10-13 | 2026-10-27 | Calibrate IV Hydration | CALIBRATE IV HYDRATION | Center for Biologics Evaluation and Research (CBER) | Unapproved New Drugs/Unlicensed Biological Product Violations | Unapproved or misbranded drugs | false | false | 1 | 2026-10-13 | 2026-10-13 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/calibrate-iv-hydration-729846-10132026 |
2026-10-08 | 2026-10-20 | snuskompagniet.com | SNUSKOMPAGNIET COM | Center for Tobacco Products | Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded | Unapproved or misbranded drugs; Adulterated; Tobacco | false | false | 1 | 2026-10-08 | 2026-10-08 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/snuskompagnietcom-739499-10082026 |
2026-10-08 | 2026-10-20 | snusi.net | SNUSI NET | Center for Tobacco Products | Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded | Unapproved or misbranded drugs; Adulterated; Tobacco | false | false | 1 | 2026-10-08 | 2026-10-08 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/snusinet-739447-10082026 |
2026-10-07 | 2026-10-20 | Olympus Medical Systems Corporation | OLYMPUS MEDICAL SYSTEMS | Center for Devices and Radiological Health | CGMP/QSR/Medical Devices/Adulterated | CGMP other or devices; Adulterated; Medical devices | false | false | 3 | 2022-12-12 | 2026-10-07 | true | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/olympus-medical-systems-corporation-729208-10072026 |
2026-10-06 | 2026-10-13 | Lovelace Biomedical Research Institute | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | Center for Drug Evaluation and Research (CDER) | Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies | null | false | false | 1 | 2026-10-06 | 2026-10-06 | false | MBT9RXJJ7428 | LOVELACE BIOMEDICAL RESEARCH INSTITUTE | 33,951,877.28 | Department of Health and Human Services | true | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lovelace-biomedical-research-institute-725136-10062026 |
2026-10-06 | 2026-10-20 | Tides Medical LLC | TIDES MEDICAL | Center for Biologics Evaluation and Research (CBER) | Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) | Medical devices | false | false | 1 | 2026-10-06 | 2026-10-06 | false | null | null | null | null | false | https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tides-medical-llc-727246-10062026 |
FDA Warning Letter Ledger: free sample (Tensorust LLC)
Every FDA warning letter in the public index, by company and violation type, with repeat recipients flagged.
Headline: A warning letter is FDA's formal notice that a company is in significant violation and must fix it, but FDA's index lists letters one at a time, with no count of who keeps getting them.
This repository is a free teaser, not the dataset. It holds 25 example rows and a summary table with no names in it. The full file has 3,722 rows and is sold by Tensorust LLC: https://tensorust.com/datasets/fda-warning-letters/.
Files here
| file | what it is |
|---|---|
sample.csv |
25 rows of the full file (the same sample shown on tensorust.com) |
summary_by_violation_categories.csv |
row counts by violation categories across the full file, no entity names (groups with fewer than 3 rows are folded into "Other") |
Summary by violation categories (largest groups)
| Violation categories | rows |
|---|---|
| Unapproved or misbranded drugs; Adulterated; Tobacco | 1,208 |
| Unapproved or misbranded drugs | 511 |
| CGMP drugs; CGMP other or devices; Adulterated | 446 |
| Food safety (FSVP, HACCP, CGMP food) | 338 |
| CGMP other or devices; Adulterated; Food safety (FSVP, HACCP, CGMP food) | 204 |
| Unapproved or misbranded drugs; Internet / COVID claims | 160 |
| (blank) | 131 |
| CGMP other or devices; Adulterated; Medical devices | 101 |
| CGMP drugs; CGMP other or devices; Unapproved or misbranded drugs; Adulterated | 66 |
| Adulterated; Compounding / outsourcing | 59 |
| Adulterated; Food safety (FSVP, HACCP, CGMP food) | 48 |
| Adulterated; Medical devices | 45 |
| TOTAL | 3,722 |
Full table: summary_by_violation_categories.csv.
What the full file has
- 3,722 rows
- Key fields: letter_date, posted_date, company, company_key, issuing_office, subject, violation_categories, response_letter, closeout_letter, letters_to_company
- Parquet and CSV, a README with sources, method and limits, and the build script
- Free 25-row sample (no personal contact data)
Coverage: 3,722 letters to 3,542 companies; the index FDA keeps online. FDA index read Nov 6, 2026.
Columns in the full file
| column | meaning |
|---|---|
letter_date |
Date on the warning letter |
posted_date |
Date FDA posted it |
company |
Recipient company |
company_key |
Ontology organization key |
issuing_office |
FDA center or office that issued it |
subject |
Subject line (violation type) as FDA lists it |
violation_categories |
Tensorust categories derived from the subject |
response_letter |
FDA posted a response letter |
closeout_letter |
FDA posted a close-out letter (issues resolved) |
letters_to_company |
Letters to the same company in the index |
first_letter |
Earliest letter to the company in the index |
latest_letter |
Latest letter to the company |
repeat_recipient |
Two or more letters to the same company |
fed_uei |
UEI of a matching federal award recipient |
fed_recipient_name |
Matching USAspending recipient |
fed_obligated_fy25_plus |
Its obligations FY2025 onward (USD) |
fed_top_agency |
Top awarding agency |
in_ontology |
Company key exists in the Tensorust ontology |
letter_url |
The letter on fda.gov |
Get the full file
| tier | price | includes |
|---|---|---|
| Warning letter file | $900 | All 3,722 warning letters in FDA's index with violation categories, close-out status, repeat-recipient counts and links. |
| Weekly warning letter feed | $6,000 a year | New letters each week as FDA posts them (it posts on Tuesdays), categorized, with repeat recipients flagged. Up to 5 users. |
| Quality and diligence license | $18,000 a year | The weekly feed firm-wide, screening of your supplier or target list, and FDA 483 and import alert joins on request. |
Email mattbusel@tensorust.com with the tier and a billing contact, and we will send a proper invoice (ACH or card). The file is delivered once the invoice is paid. Details and the live sample: https://tensorust.com/datasets/fda-warning-letters/. All datasets: https://tensorust.com/datasets/
Method and limits
The table behind FDA's warning letter page is read in four requests, two seconds apart. Letters to individual physicians and clinical investigators are removed. Company names are normalized with the ontology key to count repeat recipients and to join USAspending recipients. Categories are keyword rules on FDA's subject line.
Not FDA Form 483 observations or import alerts, and not every historical letter: it is the index FDA keeps online. A close-out flag is only set when FDA has posted one. Not regulatory advice. Letters to individual physicians and investigators are excluded.
Sources
- FDA warning letters index: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
- USAspending.gov recipients via the Tensorust ontology: https://www.usaspending.gov/
License
The sample and summary here are free to view, analyze and cite with attribution to "Tensorust LLC, https://tensorust.com/datasets/fda-warning-letters/". The full dataset is licensed separately per tier. No resale or redistribution of Tensorust data without a written license.
Tensorust LLC, Tuckahoe NY. mattbusel@tensorust.com | https://tensorust.com
- Downloads last month
- 47